ADC Therapeutics SA (ADCT)
ADC Therapeutics SA Statistics
Share Statistics
ADC Therapeutics SA has 99.18M shares outstanding. The number of shares has increased by 2.97% in one year.
| 99.18M |
| 2.97% |
| 2.48% |
| 53.89% |
| n/a |
| 300 |
| 0.06% |
Short Selling Information
The latest short interest is 4.33M, so 4.36% of the outstanding shares have been sold short.
| 4.33M |
| 4.36% |
| 5.55% |
| 9 |
Valuation Ratios
The PE ratio is -1.22 and the forward PE ratio is -2.43. ADC Therapeutics SA's PEG ratio is 0.03.
| -1.22 |
| -2.43 |
| 2.79 |
| 0.9 |
| -0.95 |
| -1.55 |
| 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for ADC Therapeutics SA.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 3.82, with a Debt / Equity ratio of -0.61.
| 3.82 |
| 3.59 |
| -0.61 |
| -1.19 |
| -0.99 |
| -2.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $263,422.05 |
| $-600,174.9 |
| 263 |
| 0.22 |
| 0.32 |
Taxes
| 166K |
| -0.11% |
Stock Price Statistics
The stock price has increased by -0.57% in the last 52 weeks. The beta is 1.96, so ADC Therapeutics SA's price volatility has been higher than the market average.
| 1.96 |
| -0.57% |
| 1.72 |
| 2.19 |
| 76 |
| 497,952 |
Income Statement
In the last 12 months, ADC Therapeutics SA had revenue of 69.28M and earned -157.85M in profits. Earnings per share was -1.62.
| 69.28M |
| 63.33M |
| -130.65M |
| -157.85M |
| -103.71M |
| -105.92M |
| -1.62 |
Balance Sheet
The company has 250.87M in cash and 123M in debt, giving a net cash position of 127.87M.
| 250.87M |
| 123M |
| 127.87M |
| -1.49B |
| 272.54M |
| 200.19M |
Cash Flow
In the last 12 months, operating cash flow was -123.83M and capital expenditures -867K, giving a free cash flow of -124.7M.
| -123.83M |
| -867K |
| -124.7M |
| -1.28 |
Margins
Gross margin is 91.41%, with operating and profit margins of -188.59% and -227.84%.
| 91.41% |
| -188.59% |
| -225.37% |
| -227.84% |
| -149.7% |
| -188.59% |
| -180% |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for ADCT is $8, which is 131.2% higher than the current price. The consensus rating is "Buy".
| $8 |
| 131.2% |
| Buy |
| 5 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -7.65 |
| 3 |